Substituted anthranilic amide derivatives and methods of use

Details Substituted anthranilic amide derivatives and methods of use Substituted anthranilic amide derivatives and methods of use

2007-12-11

2007-12-11

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S311000, C514S414000, C514S415000, C514S456000, C546S143000, C546S159000, C548S504000, C549S362000

Reexamination Certificate

active

10615809

ABSTRACT:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

REFERENCES:
patent: 3226394 (1965-12-01), Schipper
patent: 3406168 (1968-10-01), Schmidt
patent: 3452019 (1969-06-01), Shetty
patent: 3557111 (1971-01-01), Shetty
patent: 3567746 (1971-03-01), Shetty
patent: 3822277 (1974-07-01), Dufour
patent: 4321371 (1982-03-01), Parg et al.
patent: 4357333 (1982-11-01), Archibald et al.
patent: 4563467 (1986-01-01), Soler
patent: 4816485 (1989-03-01), Satzinger et al.
patent: 4857662 (1989-08-01), Satzinger et al.
patent: 5532358 (1996-07-01), Kelly
patent: 5559135 (1996-09-01), Ashton et al.
patent: 5571912 (1996-11-01), Grozinger et al.
patent: 5770613 (1998-06-01), Gaeta et al.
patent: 6008234 (1999-12-01), Kochanny et al.
patent: 6051713 (2000-04-01), Teng et al.
patent: 6140351 (2000-10-01), Arnaiz et al.
patent: 6156766 (2000-12-01), Arita et al.
patent: 6271237 (2001-08-01), Galemmo, Jr. et al.
patent: 6313122 (2001-11-01), Beight et al.
patent: 6313151 (2001-11-01), Beight et al.
patent: 6372759 (2002-04-01), Beight et al.
patent: 6417200 (2002-07-01), Beight et al.
patent: 6448277 (2002-09-01), Altmann et al.
patent: 6448290 (2002-09-01), Ohuchida et al.
patent: 6593352 (2003-07-01), Weichert et al.
patent: 6605626 (2003-08-01), Beight et al.
patent: 6610704 (2003-08-01), Beight et al.
patent: 6635657 (2003-10-01), Craft et al.
patent: 6660755 (2003-12-01), Song et al.
patent: 6794397 (2004-09-01), Cai et al.
patent: 2002/0052512 (2002-05-01), Fotouhi et al.
patent: 2003/0069250 (2003-04-01), Zhu et al.
patent: 2003/0195192 (2003-10-01), Haviv et al.
patent: 2003/0195195 (2003-10-01), Haviv et al.
patent: 2004/0063775 (2004-04-01), Momose et al.
patent: 2004/0102441 (2004-05-01), Krueger et al.
patent: 2004/0254185 (2004-12-01), Ernst et al.
patent: 2005/0032816 (2005-02-01), Ernst et al.
patent: 2005/0054654 (2005-03-01), Huth et al.
patent: 199 41 540 (2001-03-01), None
patent: 100 23 486 (2002-03-01), None
patent: 101 25 295 (2002-11-01), None
patent: 0 001 175 (1979-03-01), None
patent: 0 393 529 (1990-10-01), None
patent: 0 410 148 (1991-01-01), None
patent: 0 429 987 (1991-06-01), None
patent: 0 393 529 (1993-06-01), None
patent: 0 947 500 (1999-10-01), None
patent: 2.168.227 (1972-01-01), None
patent: 1 474 296 (1977-05-01), None
patent: 58124766 (1983-07-01), None
patent: 2000-256358 (2000-09-01), None
patent: 1156362 (1991-07-01), None
patent: WO 96/41795 (1996-12-01), None
patent: WO 98/45268 (1998-03-01), None
patent: WO 98/24771 (1998-06-01), None
patent: WO 99/32477 (1999-07-01), None
patent: WO 99/62885 (1999-12-01), None
patent: WO 00/02851 (2000-01-01), None
patent: WO 00/27819 (2000-05-01), None
patent: WO 00/27819 (2000-05-01), None
patent: WO 00/27820 (2000-05-01), None
patent: WO 0027819 (2000-05-01), None
patent: WO 00/39111 (2000-07-01), None
patent: WO 00/39117 (2000-07-01), None
patent: WO 00/39118 (2000-07-01), None
patent: WO 01/29009 (2001-04-01), None
patent: WO 01/30745 (2001-05-01), None
patent: WO 01/55114 (2001-08-01), None
patent: WO 01/55115 (2001-08-01), None
patent: WO 01/64643 (2001-09-01), None
patent: WO 01/81311 (2001-11-01), None
patent: WO 01/85671 (2001-11-01), None
patent: WO 01/85691 (2001-11-01), None
patent: WO 01/85715 (2001-11-01), None
patent: WO 02/09349 (2002-01-01), None
patent: WO 02/46148 (2002-06-01), None
patent: WO 02/090352 (2002-11-01), None
patent: WO 03/040101 (2003-05-01), None
patent: WO 03/040102 (2003-05-01), None
patent: WO 03/068232 (2003-08-01), None
patent: WO 03/068235 (2003-08-01), None
Lockeman, et al. “Nitrobenzyl Compounds and Processes in their Reduction IV” Chemische Berichte 1947, pp. 485-493.
Patani et al. “Bioisosterism: A Rational Approach in Drug Design” Chemical Reviews 1996, vol. 96, pp. 3147-3176.
Breier et al., “The role of vascular endothelial growth factor in blood vessel formation”, Trends in Cell Biology, 6:454-456 (1996).
Connell et al., “Patent foucs on cancer chemotherapeutics. II Angiogenesis agents: Apr. 2000-Sep. 2000”, Expert Opinion on Therapeutic Patents, 11(1):77-114 (2001).
Konshin et al., “Synthesis and antimicrobial activity of aryl-amides of N-(4-pyridyl)anthranilic acid”, Chemical Abstracts, 97:109837g, p. 596 (1982).
Seto et al., “Molecular Self-Assembly through Hydrogen Bonding: Supramolecular Aggregates Based on the Cyanuric Acid-Melamine Lattice”, Journal of the American Chemical Society, 115:905-916 (1993).
Singh et al., “Substituted Imidazolines and their CNS Activity”, Indian Journal of Heterocyclic Chemistry, 2:129-132 (1992).
Asakawa et al., “Chemistry of Salicylic Acid and Antrhanilic Acid. IV. Synthesis of 6-Chloro-5-sulfamoyl- and 6-Chloro-3-sulfamoylanthranilic Acid Derivatives”, Chem. Pharm. Bull., 27(6):1287-1298 (1979).
Kovac et al., “New Synthesis of 11-Acyl-5, 11-dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepin-6-ones and Related Studies”, J. Heterocyclic Chem., 20:1339 (1983).
Partridge et al., “Cyclic Amidines. Part XVIII. The Synthesis of Tricycloquinazolines by Cyclodehydrogenation”, J. Chem. Soc., 3670-3671 (1964).
Partridge et al., “Cyclic Amidines. Part XIX. derivatives of Triazabenzonaphthanthracene”, J. Chem. Soc. Abstracts, 3673-3678 (1964).
Sanchez et al., “New 7-Anilinobenzo[b][1,8]phenanthrlines”, Heterocycles, 31(11):2003-2010 (1990).
Shetty et al., “Synthesis and Activity of Some 3-Aryl- and 3-Aralkyl-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamides”, J. of Med. Chem., 13(5):886-895 (1970).
Proudfoot et al., “Novel Non-nucleoside Inhibitors or HIV-1 Reverse Transcriptase. 3. Dipyrido[2,3-b.2′,3′-e]diazepinones”, J. Med. Chem., 38:1406-1410 (1995).
Smrckova-Voltrova et al., “Structure and Properties of Quaternized 2- and 4-aminonicotinamides”, Collect. Czech. Chem. Commun., 50:1009-1015 (1995).
Samvelyan et al., “Discussion of Some New Amino Acid Derivatives of Nicotinic Acid and Their Antisoporific Properties”, Farmakologila Toksikologila, 49(3):35-37 (1986).
Hargrave et al., “Novel Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. 1. Tricyclic Pyridobenzo- and Dipyridodiazepinones”, J. Med. Chem., 34:2231-2241 (1991).
Adams et al., “Discovery and Development of a Non-nucleoside Reverse Transcriptase Inhibitor”, Royal Society of Chemistry, Recent Advances in the Chemistry of Anti-Infective Agents, 19:282-296 (1993).

Affiliated with

Also associated with

Rating

Substituted anthranilic amide derivatives and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted anthranilic amide derivatives and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted anthranilic amide derivatives and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3864561